Cardiovascular journalCurrentCardio coverage
European Heart Journal
What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.
Follow all of it, or only:You follow this. See your week →Explore Eur Heart J with filters →
- Recent
- 57 Briefs
- past 90 days
- Archive
- 653 Briefs
- research published Apr 2023 – Sep 2026 and Jan–Mar 2020
- Editorial
- –
- no Weekly issue published yet
- Impact Factor
- 45.3
- 2025 · Journal Citation Reports
Topics
- Coronary & ACS12519.1%
- Heart failure8913.6%
- Arrhythmias & EP9714.9%
- Valvular & structural487.4%
- Hypertension162.5%
- Prevention & lipids9113.9%
- Cardiometabolic & kidney182.8%
- Aortic & peripheral203.1%
- Pulmonary vascular & VTE152.3%
- Congenital132.0%
- Acute care & resuscitation50.8%
- Cardio-oncology & other385.8%
Evidence types
- Randomised controlled trials7711.8%
- Secondary analyses385.8%
- Meta-analyses6610.1%
- Cohort studies30947.3%
- Case-control studies111.7%
- Cross-sectional studies233.5%
- Diagnostic & prognostic385.8%
- Mechanistic studies91.4%
- Guidelines & statements467.0%
- Other research365.5%
Shares are of the 653 Briefs CurrentCardio has covered from Eur Heart J, by primary topic and study type; a Brief without a primary topic is in no topic row.
Publication activity
- 2026158 Briefs
- 2025175 Briefs
- 2024156 Briefs
- 2023131 Briefs
- 20222 Briefs
- 20203 Briefs
- 201927 Briefs
- 20181 Brief
Latest from European Heart Journal
Eur Heart J
Acute cellular rejection after heart transplantation: validation of HEARTBiT, a transcriptomic biomarker
Diagnostic or prognostic studyHeart failure
Eur Heart J
Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial
Secondary analysisPrevention & lipids
Eur Heart J
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation
Diagnostic or prognostic studyArrhythmias & EP
Eur Heart J
Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction
Meta-analysisCoronary & ACS
Eur Heart J
Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials
Meta-analysisPrevention & lipids
Eur Heart J
Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study
Diagnostic or prognostic studyHeart failure
Eur Heart J
Nighttime light exposure and cardiac structure and function
Cohort studyHeart failure
Eur Heart J
Subclinical liver disease and incident cardiovascular events
Cohort studyCardiometabolic & kidney
Eur Heart J
Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial
Randomised controlled trialCoronary & ACS
Eur Heart J
Eur Heart J
Ischaemic stroke in atrial flutter vs fibrillation: a Finnish nationwide study
Cohort studyArrhythmias & EP
Eur Heart J
Adverse pregnancy outcomes and long-term cardiovascular risk: lifelong connections
Research articlePrevention & lipids
Eur Heart J
Thoracic aortic disease: prognostic role of gene variants and polygenic risk scores
Research articleAortic & peripheral
Eur Heart J
Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trial
Randomised controlled trialArrhythmias & EP
Eur Heart J
Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial
Randomised controlled trialArrhythmias & EP
Eur Heart J
Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial
Randomised controlled trialPrevention & lipids
Eur Heart J
Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling
Cohort studyPrevention & lipids
Eur Heart J
Auto-regulated bioprosthetic total artificial heart as bridge to transplantation: the EFICAS study
Cohort studyHeart failure
Eur Heart J
Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England
Cross-sectional studyCardio-oncology & other
Eur Heart J
Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study
Randomised controlled trialCoronary & ACS
Eur Heart J
Mapping organ fat distribution and body composition: towards precision profiling of cardiometabolic disease risk
Cohort studyCardiometabolic & kidney
Eur Heart J
Eur Heart J
Takotsubo syndrome diagnosis: the biomarker-based BioTAK score
Diagnostic or prognostic studyCoronary & ACS
Eur Heart J
Cardiovascular Prevention among Healthcare Professionals: the ESC Congress Cardiovascular Health Check 2025
Cross-sectional studyPrevention & lipids
Eur Heart J
Eur Heart J
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis
Secondary analysisCardiometabolic & kidney
Eur Heart J
Adrenomedullin system dysregulation predicts cardiogenic shock and mortality in acute coronary syndromes
Cohort studyAcute care & resuscitation
Eur Heart J
Clonal haematopoiesis and cardiovascular-kidney-metabolic syndrome: a cohort study
Cohort studyCardiometabolic & kidney
Eur Heart J
Increasing plasma potassium and risk of atrial fibrillation: the POTCAST trial
Secondary analysisArrhythmias & EP
Eur Heart J
Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial
Randomised controlled trialCardio-oncology & other
Eur Heart J
Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk
Diagnostic or prognostic studyCardiometabolic & kidney
Eur Heart J
Local vs systemic inflammation and outcomes after percutaneous coronary intervention
Cohort studyCoronary & ACS
Eur Heart J
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
Cross-sectional studyCoronary & ACS
Eur Heart J
Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry
Cohort studyCoronary & ACS
Eur Heart J
Eur Heart J
Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study
Diagnostic or prognostic studyHeart failure
Eur Heart J
Heart transplantation allograft survival: donor atherosclerotic disease risk vs coronary angiography
Cohort studyHeart failure
Eur Heart J
Immunological risk identified by single-cell multi-omics and cardiovascular outcomes
Case-control studyPrevention & lipids
Eur Heart J
Eur Heart J